Taking a tough stance against Maryland's new pricing regulations, the generic drug industry sought an injunction, hoping to stop the law in its tracks. The case is being closely watched by other states considering similar legislation.
Taking a tough stance against Maryland's new pricing regulations, the generic drug industry sought an injunction, hoping to stop the law in its tracks. But the industry's efforts for relief have come up short, at least for now.